Inovio Pharmaceuticals Inc. (INO) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Inovio Pharmaceuticals In...

    NASDAQ: INO · Real-Time Price · USD
    2.43
    -0.03 (-1.22%)
    At close: Oct 03, 2025, 3:59 PM
    2.45
    0.82%
    After-hours: Oct 03, 2025, 07:19 PM EDT

    Inovio Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -107.25M -135.12M -279.82M -303.66M
    Depreciation & Amortization
    		 3.13M 3.5M 5.5M 4.73M
    Stock-Based Compensation
    		 6.6M 11.07M 22.56M 26.34M
    Other Working Capital
    		 -504.04K 26.4M -9.07M 13.18M
    Other Non-Cash Items
    		 -3.88M 6.47M 11.69M 858.64K
    Deferred Income Tax
    		 n/a -32.05K 4.03M 5.67M
    Change in Working Capital
    		 -2.66M -10.26M 19.83M 50.35M
    Operating Cash Flow
    		 -104.08M -124.37M -216.22M -215.71M
    Capital Expenditures
    		 -487.83K -320.9K -969.15K -1.23M
    Cash Acquisitions
    		 n/a 6.22M -2M 1,435.8B
    Purchase of Investments
    		 -54.14M -203.48M -248.53M -348.95M
    Sales Maturities Of Investments
    		 158.64M 284.93M 361.08M 174.84M
    Other Investing Acitivies
    		 -428.51K n/a n/a -1,435.8B
    Investing Cash Flow
    		 104.07M 87.36M 109.59M -175.34M
    Debt Repayment
    		 -16.41M n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 31.86M -466.65K -1.11M 2.06M
    Financial Cash Flow
    		 51.48M 5M 81.84M 211.5M
    Net Cash Flow
    		 51.5M -32.02M -24.81M -179.58M
    Free Cash Flow
    		 -104.56M -124.69M -217.18M -216.94M

    Add to Watchlist